Topical rotigotine effectively improves symptoms in patients with moderate-to-severe restless legs syndromeDrug-delivery-systemsRestless-legs-syndrome, treatmentRotigotine, therapeutic useTrial-result-clinicaldoi:10.2165/00128413-200615590-00050Inpharma Weekly...
As I mentioned in the introduction, one of the most-researched theories about the cause of restless legs syndrome is impaired dopamine signaling, which has led to the conventional treatment of RLS by dopamine agonists (i.e. chemicals that can bind to and activate dopamine receptors). Unfortunatel...
Abstract Purpose of review The aim of this article was to review the options and particularities of the treatment of restless legs syndrome (RLS) in Parkinson’s disease (PD). Recent findings RLS is more frequent in PD than in the general population. Even if these two disorders share some s...
The present invention provides methods of treating Restless Legs Syndrome (RLS) including administering to a subject an effective amount of a dopamine D1 receptor antagon
The invention is directed to a method of treating restless legs syndrome in a subject, comprising administering a therapeutically effective amount of a carbamate compound, or pharma
Objective: To evaluate the potential of onabotulinum toxin A (Botox, Allergan, Inc., Irvine, California) in the treatment of restless legs syndrome (RLS). Methods: A single-arm, open-label pilot trial of onabotulinum toxin A was conducted to determine its usefulness as an injectable treatment...
The present invention is directed to a method for treating symptoms associated with Restless Legs Syndrome (RLS). The method includes administering to a warm-blooded an
the time spent self-grooming was recorded using a specific software able to analyze the repetitive attitude in washing the head, the body, the genital area, the tail and in licking paws and legs. Analyses of atypical motor stereotypies (walking backwards and in circles) were instead observed ...